At the tumor site, Mo-MDSC are rapidly committed to TAMs that historically exert a high ability to suppress T cell responses, in particular by producing nitric oxide and immune suppressive cytokines and expressing Arg1 (44). Here, ARG1 is linked to neoplasm.